CHTH · As filed with the SEC
CNL Healthcare Properties balance sheet, by quarter
The statement as CNL Healthcare Properties presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) · USD thousands
| USD thousands | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Real estate investment properties, net | 1,217,132 | 1,225,553 | 1,234,228 | 1,244,663 | 1,252,461 | 1,259,654 | 1,269,283 | 1,279,137 |
| Cash | 57,696 | 53,185 | 50,949 | 44,011 | 50,516 | 49,086 | 42,364 | 54,097 |
| Restricted cash | 2,390 | 2,334 | 2,366 | 1,602 | 3,045 | 2,460 | 3,342 | 1,791 |
| Other assets | 15,230 | 12,183 | 16,334 | 19,095 | 18,918 | 18,104 | 19,341 | 19,127 |
| Deferred rent, lease incentives and intangibles, net | 9,290 | 9,303 | 9,567 | 9,970 | 10,366 | 10,740 | 11,070 | 11,386 |
| Total assets | 1,301,738 | 1,302,558 | 1,313,444 | 1,319,341 | 1,335,306 | 1,340,044 | 1,345,400 | 1,365,538 |
| LIABILITIES AND EQUITY | ||||||||
| Liabilities: | ||||||||
| Mortgages and other notes payable, net | 0 | 0 | 0 | 15,748 | 36,017 | 36,200 | 36,376 | 36,569 |
| Credit facilities, net | 563,293 | 562,637 | 566,992 | 550,389 | 533,752 | 533,114 | 532,477 | 541,840 |
| Accounts payable and accrued liabilities | 32,143 | 27,790 | 28,289 | 28,871 | 32,073 | 27,826 | 28,407 | 31,322 |
| Nonrelated Party | 11,281 | 11,268 | 11,816 | 11,225 | 12,695 | 8,817 | 8,669 | 10,475 |
| Related Party | 1,412 | 1,381 | 1,454 | 1,327 | 177 | 1,326 | 1,413 | 1,292 |
| Total liabilities | 608,129 | 603,076 | 608,551 | 607,560 | 614,714 | 607,283 | 607,342 | 621,498 |
| Stockholders' equity: | ||||||||
| Preferred stock, $0.01 par value per share, 200,000 shares authorized; none issued or outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Excess shares, $0.00 par value per share, 300,000 shares authorized; none issued or outstanding | — | — | — | — | — | 0 | 0 | 0 |
| Excess shares, $0.01 par value per share, 300,000 shares authorized; none issued or outstanding | 0 | 0 | 0 | 0 | 0 | — | — | — |
| Common stock, $0.01 par value per share, 1,120,000 shares authorized, 187,958 shares issued and 175,274 shares outstanding | 1,739 | 1,739 | 1,739 | 1,739 | 1,739 | 1,739 | 1,739 | 1,739 |
| Capital in excess of par value | 1,515,799 | 1,515,799 | 1,515,799 | 1,515,799 | 1,516,806 | 1,516,806 | 1,516,806 | 1,516,806 |
| Accumulated income | 54,610 | 56,188 | 57,680 | 60,248 | 65,199 | 68,373 | 69,675 | 74,710 |
| Accumulated distributions | (878,291) | (873,838) | (869,385) | (864,932) | (860,479) | (856,026) | (851,573) | (847,120) |
| Accumulated other comprehensive loss | (248) | (406) | (940) | (1,073) | (3,193) | 1,368 | 919 | (2,572) |
| Total stockholders' equity | 693,609 | 699,482 | 704,893 | 711,781 | 720,072 | 732,260 | 737,566 | 743,563 |
| Noncontrolling interest | — | — | — | 0 | 520 | 501 | 492 | 477 |
| Total equity | — | — | — | 711,781 | 720,592 | 732,761 | 738,058 | 744,040 |
| Total liabilities and equity | 1,301,738 | 1,302,558 | 1,313,444 | 1,319,341 | 1,335,306 | 1,340,044 | 1,345,400 | 1,365,538 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.
Data on this page was fetched . The filing on SEC.gov is the record.